Incyte
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.About INCY
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.
INCY Key Statistics
Stock Snapshot
With a market cap of 23.55B, Incyte(INCY) trades at $116.17. The stock has a price-to-earnings ratio of 14.43.
During the trading session on 2026-10-20, Incyte(INCY) shares reached a daily high of $117.00 and a low of $113.26. At a current price of $116.17, the stock is +2.6% higher than the low and still -0.7% under the high.
Trading activity shows a volume of 328.39K, compared to an average daily volume of 1.74M.
The stock's 52-week range extends from a low of $84.02 to a high of $132.60.
The stock's 52-week range extends from a low of $84.02 to a high of $132.60.
INCY News
Over the last 7 days, the United States market has experienced a 1.8% drop, yet it remains up by 11% over the past year with earnings forecasted to grow by 17%...
...
Incyte (INCY) announced that it will present new data from its oncology portfolio during the European Society of Medical Oncology, ESMO, Congress 2026, being he...
Analyst ratings
52%
of 31 ratingsMore INCY News
Truist analyst Srikripa Devarakonda raised the firm’s price target on Incyte (INCY) to $115 from $105 and keeps a Hold rating on the shares. The firm has update...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.